Friday, March 25, 2022

MARUTI

MARUTI(Maruti Suzuki India Limited)

13.01.2023 - MS on Maruti Maintain Overweight CMP 8855 Target 10483
23.11.2022 - UBS on Maruti Maintain Buy CMP 9025 Target 12000
31.10.2022 - Kotak Instl Eq on Maruti Maintain Sell CMP 9535 Target 8150
31.10.2022 - CLSA on Maruti Maintain Sell CMP 9535 Target 7597
31.10.2022 - JpMorgan on Maruti Maintain Neutral CMP 9535 Target 8700
31.10.2022 - CITI on Maruti Maintain Buy CMP 9535 Target 12500
31.10.2022 - GS on Maruti Maintain Buy CMP 9535 Target 11250
28.10.2022 - GS on Maruti Maintain Buy CMP 9535 Target 10600
13.10.2022 - CLSA on Maruti Maintain Sell CMP 8664 Target 7597

07.10.2022 - GS on Maruti Maintain Buy CMP 8750 Target 10500
27.09.2022 - MS on Maruti Maintain Overweight CMP 8777 Target 9839
27.09.2022 - CLSA on Maruti Maintain Sell CMP 8777 Target 7374
27.09.2022 - Nomura on Maruti Maintain Neutral CMP 8777 Target 8970
12.09.2022 - UBS on Maruti Maintain Buy CMP 8922 Target 10500
01.07.2022 - CLSA on Maruti Maintain Sell CMP 8471 Target 7053
01.07.2022 - Nomura on Maruti Maintain Neutral CMP 8471 Target 8627
29.06.2022 - CLSA on Maruti Maintain Sell CMP 8438.1 Target 7053
27.06.2022 - BOFA on Maruti Maintain Buy CMP 8425 Target 9500
24.06.2022 - JpMorgan on Maruti Maintain Neutral CMP 8254.9 Target 8200
16.06.2022 - Jefferies on Maruti Maintain Buy CMP 7853.45 Target 10250
13.06.2022 - UBS on Maruti Maintain Buy CMP 7901.4 Target 10000
02.05.2022 - Nomura on Maruti Maintain Neutral CMP 7717 Target 8627
02.05.2022 - BOFA on Maruti Maintain Buy CMP 7717 Target 8750
26.04.2022 - MS on Maruti Maintain Overweight CMP 7908 CMP 9473
05.04.2022 - HSBC on Maruti Maintain Buy CMP 7740 Target 9500
25.03.2022 - CLSA on MARUTI Maintain Sell CMP 7533 Target 6430
17.02.2022 - CLSA on Maruti Maintain Sell CMP 8583 Target 6440
27.01.2022 - CS on Maruti Maintain Outperform CMP 8603 Target 10389
27.01.2022 - Macquarie on Maruti Maintain Outperform CMP 8603 Target 9753
27.01.2022 - CITI on Maruti Maintain Outperform CMP 8603 Target 10000
27.01.2022 - Gs on Maruti Maintain Outperform CMP 8603 Target 10100
27.01.2022 - CLSA on Maruti Maintain Sell CMP 8603 Target 6440
27.01.2022 - KotakInstl On Martui Maintain Sell CMP 8603 Target 7800
18.01.2022 - GS on Maruti Maintain Buy CMP 8266 Target 9100
18.01.2022 - CLSA on Martui Maintain Sell CMP 8266 Target 6420
03.01.2022 - GS on Maruti Buy, TP Rs 9000

MACQUARIE ON MARUTI : 02.09.2021

* MAINTAIN NEUTRAL TARGET: 6,800
* Management Sees Sep Production At 40% Of Normal Level
* We See 7-19% Downside To Our FY22 Volume Estimate
• Timing & Intensity Of Recovery In Semiconductor Supply Is Key
* Current Valuations Cap Downside Risk

GOLDMAN SACHS ON MARUTI : 01.09.2021

• Maintain BUY, Target at Rs 9036/share
* Chip shortage to cause further production cuts in September
• Cut FY22E EBITDA by 5%, FY23 / FY24 estimates mostly unchanged
* September production cuts due to semiconductor shortages
* Vol impact to be partially offset by price hikes

MORGAN STANLEY ON MARUTI : 29.07.2021

• Maintain Overweight, Target at Rs 8,307/share
* Troughs in margins, volumes, and the model cycle keep us OW
• P/E in the context of depressed earnings is also attractive
• India's PV cycleisata multi-year low; reiterate OW

BERNSTEIN ON MARUTI : 29.07.2021

* Bernstein maintains OUTPERFORM rating on Maruti as management indicates a recovery in overall demand
* Q1 Results Reflect Challenges On Multiple Fronts
* Commodity Prices Continue An Uptrend & Not Fully Offset By Price Increase In Recent Months
* COVID-related Production Disruption Impacted Operating Leverage
* Commencement of Provisioning For Wage Revision In A Weak Quarter Was An Additional Impact
• Mgmt Commentary Indicated Recovery In Overall Demand
* MAINTAIN OUTPERFORM TARGET: 7,850

KOTAK INSTITUTIONAL EQ ON MARUTI : 29.07.2021

* Maruti's Q1 EBITDA 5% below our expectations due to higher input costs & employee expenses, Kotak Institutional Equities says, maintains SELL call
* Q1 EBITDA 5% Below Our Expectations Due To Higher Input Costs & Employee Expenses
* Volume Growth Outlook Remains Strong Given Strong Order Backlog
* Maintain Sell As We Are Concerned On Market Share Loss In SUV Segment & Rich Valuations
* MAINTAIN SELL TARGET: 6,000

ERIS

ERIS(Eris Lifesciences Ltd) 18.01.2023 -  Macquarie  on  ERIS Maintain Outperform CMP 625.75 Target 830